The scanner features advanced identification technology. Credit: zlikovec / Shutterstock.

Positron, a molecular imaging medical device company, has signed an exclusive agreement to sell and distribute the NeuSight PET-CT 64 slice scanner in North America.

The agreement with Shenyang Intelligent Neuclear Medical Technology, a subsidiary of Neusoft Medical Systems, positions Positron to introduce the scanner to the nuclear cardiac imaging market next month.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Approved by the US Food and Drug Administration (FDA), the NeuSight PET-CT 64 slice scanner offers high performance and has been installed worldwide.

Designed for clinical exploration and data acquisition, the scanner features advanced identification technology for improved scanning speed and precision.

Positron president Adel Abdullah said: “The NeuSight PET-CT has been extremely successful for Neusoft Medical Systems with approximately 500 systems sold internationally, and we are confident for the NeuSight system to have similar success in the US, the largest imaging devices market, as well as Canada and Mexico.

“NeuSight PET-CT is an ideal versatile scanner suitable for SPECT providers adopting the PET modality, as well as oncology practices seeking new systems for enhanced diagnostic and disease management capabilities.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

“Positron’s PET-CT and services are the best value of technology and practice sustainability in the industry, and we believe our new system offers the perfect balance of quality, speed, size, and low cost to own and operate for any nuclear medicine provider seeking the best in PET imaging.”

The NeuSight PET-CT system offers anatomic and functional imaging with qualified designs and technology. It is versatile, catering to multiple molecular imaging applications including heart, tumour, and brain studies.

Last year, Positron and Ochsner Clinic Foundation planned to commence a clinical study of the Affinity PET-CT imaging device.